Diabetes pill shows promise in Real-World setting
NCT ID NCT05230589
Summary
This study observed how well the once-daily oral medication Rybelsus (semaglutide) worked for managing type 2 diabetes in everyday life in Saudi Arabia. It involved 194 adults who were prescribed the medication by their doctor as part of their normal care. Researchers tracked changes in blood sugar levels and body weight over 8-10 months to see the medication's real-world effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Master Centre for Saudi
Riyadh, 3542, Saudi Arabia
-
Specialized Medical Cente
Riyadh, Saudi Arabia
Conditions
Explore the condition pages connected to this study.